Mechanism of Huoxue Dingxuan Capsules on autophagy in vascular endothelial cells based on "crosstalk" of Bcl-2 and mTOR protein.
10.19540/j.cnki.cjcmm.20240712.704
- Author:
Yan-Long GONG
1
;
Kai WANG
2
;
Yong-Jia SONG
3
;
Xiao-Yu LIU
3
;
Min SONG
3
Author Information
1. Department of Orthopedics,Affiliated Hospital of Gansu University of Chinese Medicine Lanzhou 730020,China.
2. Department of Orthopedics, Gansu Provincial People's Hospital Lanzhou 730000,China.
3. Clinical College of Chinese Medicine,Gansu University of Chinese Medicine Lanzhou 730000,China.
- Publication Type:Journal Article
- Keywords:
"crosstalk";
Bcl-2;
Huoxue Dingxuan Capsules;
autophagy;
cervical spondylosis of vertebral artery type;
mTOR
- MeSH:
Autophagy/drug effects*;
TOR Serine-Threonine Kinases/genetics*;
Drugs, Chinese Herbal/pharmacology*;
Endothelial Cells/metabolism*;
Proto-Oncogene Proteins c-bcl-2/metabolism*;
Animals;
Mice;
Capsules;
Humans
- From:
China Journal of Chinese Materia Medica
2024;49(21):5695-5703
- CountryChina
- Language:Chinese
-
Abstract:
This paper investigated the mechanism of Huoxue Dingxuan Capsules(HXDX) on autophagy in vascular endothelial cells based on the "crosstalk" of Bcl-2 and mTOR protein. bEnd.3 cells were divided into a blank control group, a model group, and an HXDX group. CO-IP experiments were conducted, and then Western blot(WB) was used to detect the binding of Bcl-2 and mTOR. Co-localization of Bcl-2 with mTOR protein was observed by laser confocal microscopy after staining. The model of Bcl-2 siRNA in bEnd.3 cells was constructed, and the bEnd.3 cells were divided into five groups, including blank control group, oxygen-glucose deprivation(OGD) group, transfected Bcl-2 siRNA group, negative control(NC) group, and HXDX group. The model of mTOR siRNA in bEnd.3 cells was constructed, and the bEnd.3 cells were divided into five groups, including blank control group, OGD group, transfected mTOR siRNA group, NC group, and HXDX group. The expression of autophagy-related proteins was detected by WB. The results of CO-IP experiments showed that Bcl-2 and mTOR proteins could be co-localized and expressed in bEnd.3 cells, and the expression of Bcl-2 and mTOR proteins increased after the intervention of the HXDX-containing serum. After screening and transfection with Bcl-2-mus-384, autophagy of bEnd.3 cells was induced. The expression of Bcl-2 in the Bcl-2 siRNA group was significantly decreased compared with the blank control group and model group. The expression of mTOR protein was significantly lower than that of the OGD group, and the expression of human microtubule-associated protein light chain 3Ⅱ/Ⅰ was significantly higher than that of the model group. After the intervention of the HXDX-containing serum, the expression of Bcl-2 and mTOR was increased in the HXDX group compared with that in the Bcl-2 siRNA group, and the expression of LC3Ⅱ/LC3Ⅰ and Beclin1 was decreased in the HXDX group compared with that in the Bcl-2 siRNA group. After transfecting mTOR-mus-7061 and inducing autophagy of bEnd.3 cells, in the mTOR siRNA group, mTOR protein expression was decreased compared with the blank control and model groups, and LC3Ⅱ/LC3Ⅰ and Beclin1 protein expression was increased compared with the model group. After the intervention of the HXDX-containing serum, the expression of Bcl-2 and mTOR was increased in the HXDX group compared with that in the mTOR siRNA group, and the expression of LC3Ⅱ/LC3Ⅰ and Beclin1 proteins was decreased compared with the mTOR siRNA group. This study explored the "crosstalk" of Bcl-2 and mTOR during autophagy in bEnd.3 cells at the cellular level and illustrated the modulating effect of the HXDX-containing serum, which provided a basis for the treatment of cervical spondylosis of vertebral artery type.
